Evidence on the economic burden of Chronic Obstructive Pulmonary Disease (COPD) globally is becoming a crucial factor in assisting health authorities in improving resource allocation. An extensive study has been conducted to summarize the economic burden evidence for COPD from 1990 to 2019.
The study examined the economic burden of COPD from 1990 to 2019 through a systematic review of online databases, including Web of Science, PubMed/Medline, Scopus, and the Cochrane Library. A meticulous screening of 12,734 studies resulted in 43 articles that met the inclusion criteria. The information and data on direct, indirect, and intangible costs were extracted and converted to 2018 international dollars.
Economic Burden Study Highlights Vast Disparities in COPD Costs and Urges More Support for Caregivers
The results revealed a range of total direct costs from Int$ 52.08 (India) to Int$ 13,776.33 (Canada) across 16 studies. Drug costs ranged from Int$ 70.07 (Vietnam) to Int$ 8,706.9 (China) in eleven studies. Eight studies explored indirect costs, while one highlighted caregivers’ direct costs at approximately Int$ 1,207.8 (Greece).
The study underscores the limited research on COPD caregivers’ burdens, particularly in developing countries. The importance of increased research support, particularly in high-resource settings, is emphasized.
Providing information about the cost and demographics of the COPD economic burden from 1990 to 2019, the study suggests that more strategies should be implemented to reduce the frequency of hospital admissions and acute care services. This will improve the lives of COPD patients and control the rising cost and burden of the disease.
Original Article DOI: 10.4046/trd.2023.0100
Original title: Economic burden of chronic obstructive pulmonary disease: A systematic review
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
